Multizonal observational study conducted by clinical practitioners on evolocumab use in subjects with hyperlipidemia in Saudi Arabia and Kuwait: Results from the ZERBINI study

Dyslipidemia is a prevalent condition with significant morbidity and mortality across the world, including in the Arabian Gulf. The present study aimed to describe the characteristics of patients receiving evolocumab in clinical practice. ZERBINI was a multi-country, observational, retrospective/pro...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	PloS one Ročník 18; číslo 1; s. e0278821
Hlavní autoři:	Al Faraidy, Khalid, Akbar, Mousa, Shehri, Mohamed, Aljarallah, Mohammad, Abdin Hussein, Gamal, Dashti, Raja, Al Qudaimi, Ahmad, Al Nouri, Fahad, Awan, Zuhier, Essam, Ahmed, Emara, Alaa
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Public Library of Science 20.01.2023 Public Library of Science (PLoS)
Témata:	Adult Anticholesteremic Agents - adverse effects Biology and Life Sciences Cardiovascular disease Cholesterol Cholesterol, LDL Coronary artery disease Diabetes Drug dosages Drug therapy Dyslipidemia Health services Heart attacks Heart diseases Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hyperlipidemia Hyperlipidemias - drug therapy Hypertension Kuwait - epidemiology Lipids Local population Low density lipoprotein Medicine and Health Sciences Metabolic disorders Monoclonal antibodies Morbidity Observational studies Patients People and places Prospective Studies Retrospective Studies Saudi Arabia Statins Statistical analysis Saudi Arabia Kuwait Middle East
ISSN:	1932-6203, 1932-6203
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!